165 related articles for article (PubMed ID: 4345475)
21. Effects of prostaglandins on basal and stimulated thyroid function.
Burke G
Am J Physiol; 1970 May; 218(5):1445-52. PubMed ID: 4314571
[No Abstract] [Full Text] [Related]
22. [Thyrotropic hormone and the thyroid gland (present status)].
Kalinin AP; Izmaĭlov GI
Ter Arkh; 1977; 49(12):131-7. PubMed ID: 414369
[No Abstract] [Full Text] [Related]
23. Comparison of early effects of thyrotropin and long-acting thyroid stimulator on thyroid secretion.
Shishiba Y; Solomon DH; Beall GN
Endocrinology; 1967 May; 80(5):957-61. PubMed ID: 6023563
[No Abstract] [Full Text] [Related]
24. Thyroid fetomaternal relationship in iodine deficiency.
Delange F
Forum Nutr; 2003; 56():61-3. PubMed ID: 15806798
[No Abstract] [Full Text] [Related]
25. Thyroid stimulators and thyroid stimulation.
Burke G
Acta Endocrinol (Copenh); 1971 Mar; 66(3):558-76. PubMed ID: 4323505
[No Abstract] [Full Text] [Related]
26. The long-acting thyroid stimulator and thyroid disease.
Kriss JP
Adv Intern Med; 1970; 16():135-54. PubMed ID: 4247613
[No Abstract] [Full Text] [Related]
27. Mechanism of action of di-iodotyrosine and of iodine.
Fôldes J; Gesztesi E; Juhász J
Acta Med Acad Sci Hung; 1974; 31(1-2):131-7. PubMed ID: 4464746
[No Abstract] [Full Text] [Related]
28. A new in vitro assay for thyroid-stimulating hormone.
Brown J; Munro DS
J Endocrinol; 1967 Aug; 38(4):439-49. PubMed ID: 4291529
[No Abstract] [Full Text] [Related]
29. [Regulation of the thyroid gland--the roles of cAMP and prostaglandins--and Graves' disease].
Takasu N
Horumon To Rinsho; 1983 Apr; 31(4):325-49. PubMed ID: 6309437
[No Abstract] [Full Text] [Related]
30. Studies of a sibship with apparent hereditary resistance to the intracellular action of thyroid hormone.
Refetoff S; DeGroot LJ; Benard B; DeWind LT
Metabolism; 1972 Aug; 21(8):723-56. PubMed ID: 5047916
[No Abstract] [Full Text] [Related]
31. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
McKenzie JM
Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
[No Abstract] [Full Text] [Related]
32. The action of thyrotropin on thyroid metabolism.
Dumont JE
Vitam Horm; 1971; 29():287-412. PubMed ID: 4400011
[No Abstract] [Full Text] [Related]
33. The long-acting thyroid stimulator of Graves' disease.
Burke G
Am J Med; 1968 Sep; 45(3):435-50. PubMed ID: 4876801
[No Abstract] [Full Text] [Related]
34. The influence of adrenergic receptor blocking agents on the mouse thyroid.
Kendall-Taylor P; Munro DS
Clin Sci; 1970 Dec; 39(6):781-91. PubMed ID: 4099708
[No Abstract] [Full Text] [Related]
35. Effect of thyrotropin and of LATS on mouse thyroid cyclic AMP.
Zakarija M; McKenzie JM
Metabolism; 1973 Sep; 22(9):1185-91. PubMed ID: 4353647
[No Abstract] [Full Text] [Related]
36. [The cyclic adenylcyclase AMP system as a modulator of thyroid homeostasis. Physiopathological and clinical implications].
D'Armiento M; Andreoli M; Anguissola AB
Recenti Prog Med; 1974 Jan; 56(1):24-46. PubMed ID: 4363426
[No Abstract] [Full Text] [Related]
37. Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
Wong ET; Doe RP
Ann Intern Med; 1972 Jan; 76(1):77-84. PubMed ID: 4112158
[No Abstract] [Full Text] [Related]
38. A comparison of the actions of thyroid-stimulating hormone and the long-acting thyroid stimulator in an in vitro assay.
Brown J; Ensor J; Munro DS
Proc R Soc Med; 1968 Jul; 61(7):652-4. PubMed ID: 5664277
[No Abstract] [Full Text] [Related]
39. In vitro influence of thyrotropin or long-acting thyroid stimulator on mouse thyroid membrane potential.
Konno N; McKenzie JM
Metabolism; 1970 Oct; 19(10):724-34. PubMed ID: 5506399
[No Abstract] [Full Text] [Related]
40. Reduced sensitivity of the thyroid to thyrotrophic hormone and LATS following treatment with antimicrosomal antibodies.
Földes J; Takó J; Bános C; Gesztesi E; Juhász J
Acta Endocrinol (Copenh); 1973 Dec; 74(4):675-84. PubMed ID: 4800904
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
